+Search query
-Structure paper
Title | Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib inKRAS-Mutant Pancreatic and Colorectal Cancer. |
---|---|
Journal, issue, pages | Cancer Res., Vol. 79, Page 2367-2378, Year 2019 |
Publish date | Aug 28, 2018 (structure data deposition date) |
![]() | Weisner, J. / Landel, I. / Reintjes, C. / Uhlenbrock, N. / Trajkovic-Arsic, M. / Dienstbier, N. / Hardick, J. / Ladigan, S. / Lindemann, M. / Smith, S. ...Weisner, J. / Landel, I. / Reintjes, C. / Uhlenbrock, N. / Trajkovic-Arsic, M. / Dienstbier, N. / Hardick, J. / Ladigan, S. / Lindemann, M. / Smith, S. / Quambusch, L. / Scheinpflug, R. / Depta, L. / Gontla, R. / Unger, A. / Muller, H. / Baumann, M. / Schultz-Fademrecht, C. / Gunther, G. / Maghnouj, A. / Muller, M.P. / Pohl, M. / Teschendorf, C. / Wolters, H. / Viebahn, R. / Tannapfel, A. / Uhl, W. / Hengstler, J.G. / Hahn, S.A. / Siveke, J.T. / Rauh, D. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 2.9 Å |
Structure data | ![]() PDB-6hhf: |
Chemicals | ![]() ChemComp-G4K: ![]() ChemComp-HOH: |
Source |
|
![]() | TRANSFERASE / Akt1 / borussertib / covalent-allosteric |